Divi's Laboratories Overview
Share Price
$31.50
(As of Friday Closing)
Divi's Laboratories General Information
Description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. Divi operates two segments: the first is Generic APIs and Nutraceuticals, and the second is Custom Synthesis of APIs, intermediates, and specialty ingredients for innovators. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Divi's Laboratories Stock Performance
(As of Tuesday closing)
| Stock Price |
Previous Close |
52 wk Range |
Market Cap |
Shares |
Average Volume |
EPS |
| $31.50 |
$30.11 |
$20.60 - $32.41 |
$8.36B |
265M |
937K |
$0.68 |
Divi's Laboratories Financials Summary
In Thousands,
USD
|
TTM
31-Dec-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
| EV |
6,767,537 |
6,217,893 |
4,201,945 |
2,428,640 |
| Revenue |
747,695 |
706,684 |
603,600 |
605,921 |
| EBITDA |
275,005 |
288,403 |
212,501 |
225,767 |
| Net Income |
181,580 |
193,269 |
136,031 |
158,090 |
| Total Assets |
|
1,157,428 |
1,042,306 |
949,645 |
| Total Debt |
0 |
15,205 |
9,694 |
5,511 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Divi's Laboratories Valuation & Funding
| Deal Type |
Date |
Amount |
Valuation/
EBITDA |
Post-Val |
Status |
Debt |
This information is available in the PitchBook Platform. To explore Divi's Laboratories‘s full profile, request access.
Request a free trial
Divi's Laboratories Executive Team (1)
| Name |
Title |
Board Seat |
Contact Info |
| Murali Divi Ph.D |
Chairman & Managing Director |
|
|
Divi's Laboratories Board Members (1)
| Name |
Representing |
Role |
Since |
| 000000 0000 00.0 |
Divi's Laboratories |
Chairman & Managing Director |
000 0000
|
Divi's Laboratories Investors
| Investor Name |
Investor Type |
Holding |
Investor Since |
Participating Rounds |
Contact Info |
This information is available in the PitchBook Platform. To explore Divi's Laboratories‘s full profile, request access.
Request a free trial